Safety Monitoring of COVID-19 mRNA Vaccine First Booster Doses Among Persons Aged ≥12 Years with Presumed Immunocompromise Status — United States, January 12, 2022–March 28, 2022

Detalles Bibliográficos
Autores principales: Hause, Anne M., Baggs, James, Marquez, Paige, Abara, Winston E., Baumblatt, Jane Gwira, Thompson, Deborah, Su, John R., Myers, Tanya R., Gee, Julianne, Shimabukuro, Tom T., Shay, David K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2022
Materias:
Full Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9290389/
https://www.ncbi.nlm.nih.gov/pubmed/35834416
http://dx.doi.org/10.15585/mmwr.mm7128a3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9290389/
https://www.ncbi.nlm.nih.gov/pubmed/35834416
http://dx.doi.org/10.15585/mmwr.mm7128a3

Ejemplares similares